New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2014
11:10 EDTFURX, TKPYYFuriex confirms Takeda to present additional EXAMINE trial data
Furiex Pharmaceuticals (FURX) confirmed that its partner Takeda Pharmaceuticals (TKPYY) will present sub-analyses from the global EXAMINE, EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome, cardiovascular safety outcomes trial in a poster session at the American College of Cardiology’s 63rd Annual Scientific Session. These sub-analyses specifically relate to the effects of alogliptin on rates of CV mortality and hospitalization for heart failure, Furiex said. Findings from one sub-analysis demonstrated no effect on rates of CV mortality. There was also no increase in sudden cardiac death with alogliptin. The other sub-analysis demonstrated that in patients with Type 2 diabetes and recent ACS, the pre-specified composite CV outcome of first occurrence of all-cause mortality, nonfatal myocardial infarction and stroke, urgent revascularization due to unstable angina, and hospitalization for heart failure was similar for alogliptin compared with placebo.
News For FURX;TKPYY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 27, 2014
19:48 EDTTKPYYEli Lilly responds to ruling in Takeda case
Eli Lilly (LLY) issued the following statement in response to a judge's ruling that the punitive damages awarded in the case of Terrence Allen, et al. v. Takeda Pharmaceuticals (TKPYY) be reduced. The judge reduced the punitive damages from $3B for Lilly and $6B for Takeda to $9.2M for Lilly and $27.6M for Takeda. Plaintiffs also were awarded $1.27M in compensatory damages. The allocation of liability was 75% Takeda, 25% Lilly. "While we have empathy for the plaintiff, we believe the evidence did not support his claims," said Mike Harrington, senior VP and general counsel, Lilly. "We will continue working vigorously to overturn the verdict."
18:45 EDTTKPYYTakeda Pharmaceutical Co. Ltd. reponds to ruling in diabetes drug case
Subscribe for More Information
17:31 EDTTKPYYEli Lilly, Takeda have Actos award cut to $36.8M from $9B, Bloomberg reports
Subscribe for More Information
October 16, 2014
15:10 EDTTKPYYAmerican College of Gastroenterology to hold annual meeting
ACG Annual Scientific Meeting 2014 to be held in Philadlephia, PA on October 17-22.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use